JP5799024B2 - 新規化合物 - Google Patents
新規化合物 Download PDFInfo
- Publication number
- JP5799024B2 JP5799024B2 JP2012544816A JP2012544816A JP5799024B2 JP 5799024 B2 JP5799024 B2 JP 5799024B2 JP 2012544816 A JP2012544816 A JP 2012544816A JP 2012544816 A JP2012544816 A JP 2012544816A JP 5799024 B2 JP5799024 B2 JP 5799024B2
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- phenyl
- pyridin
- mixture
- thieno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- WOELUHGOQLUNTN-UHFFFAOYSA-N CC(C)(C)OC([n]1ncc(-c([s]c2c3c(NS(c4ccccc4)(=O)=O)cc(C)n2)c3Br)c1)=O Chemical compound CC(C)(C)OC([n]1ncc(-c([s]c2c3c(NS(c4ccccc4)(=O)=O)cc(C)n2)c3Br)c1)=O WOELUHGOQLUNTN-UHFFFAOYSA-N 0.000 description 1
- KHNDGDMDYRDYBR-UHFFFAOYSA-N CCCC(N(C)OC)=O Chemical compound CCCC(N(C)OC)=O KHNDGDMDYRDYBR-UHFFFAOYSA-N 0.000 description 1
- BCZTWLRHZSZNAX-WBIWJJLGSA-N CCCC/C(/OC)=C\CC[C@](C)(C1)SC2=C1C[C@H](C)[C@@]1(C)N2C1 Chemical compound CCCC/C(/OC)=C\CC[C@](C)(C1)SC2=C1C[C@H](C)[C@@]1(C)N2C1 BCZTWLRHZSZNAX-WBIWJJLGSA-N 0.000 description 1
- 0 CCN(CCN(C)c1c(C)ccc(-c2c(C)[s]c3c2C(NS(*(C=C(C=CC)Cl)=C)(O)=O)=C[C@](C)N3)c1)C(OC(C)(C)C)=O Chemical compound CCN(CCN(C)c1c(C)ccc(-c2c(C)[s]c3c2C(NS(*(C=C(C=CC)Cl)=C)(O)=O)=C[C@](C)N3)c1)C(OC(C)(C)C)=O 0.000 description 1
- XQRDGCKGXQDHGN-UHFFFAOYSA-N CCOC(c(c(C)nc([s]1)c2c(C)c1Br)c2NS(c1cc(Cl)ccc1)(=O)=O)=O Chemical compound CCOC(c(c(C)nc([s]1)c2c(C)c1Br)c2NS(c1cc(Cl)ccc1)(=O)=O)=O XQRDGCKGXQDHGN-UHFFFAOYSA-N 0.000 description 1
- IBUYYWDLGDOLBD-UHFFFAOYSA-N CCOC(c(c(C)nc1c2c(-c3cc(OC)ccc3)c[s]1)c2N)=O Chemical compound CCOC(c(c(C)nc1c2c(-c3cc(OC)ccc3)c[s]1)c2N)=O IBUYYWDLGDOLBD-UHFFFAOYSA-N 0.000 description 1
- QEDSBOVKPQYQKK-UHFFFAOYSA-N COc(ccc(-c1c[s]c(N)c1C#N)c1)c1OC Chemical compound COc(ccc(-c1c[s]c(N)c1C#N)c1)c1OC QEDSBOVKPQYQKK-UHFFFAOYSA-N 0.000 description 1
- FDQYXLXSYCPUNC-UHFFFAOYSA-N Cc([s]c1c2c(N)cc(C)n1)c2C#N Chemical compound Cc([s]c1c2c(N)cc(C)n1)c2C#N FDQYXLXSYCPUNC-UHFFFAOYSA-N 0.000 description 1
- HGDYJEDTIIKJIJ-UHFFFAOYSA-N Cc([s]c1c2c(NS(c(cc3)ccc3Cl)(=O)=O)cc(C)n1)c2-c1cccc(OC)c1 Chemical compound Cc([s]c1c2c(NS(c(cc3)ccc3Cl)(=O)=O)cc(C)n1)c2-c1cccc(OC)c1 HGDYJEDTIIKJIJ-UHFFFAOYSA-N 0.000 description 1
- LHTXRSDBPAMQJV-UHFFFAOYSA-N Cc([s]c1c2c(NS(c3cc(Cl)ccc3)(=O)=O)cc(C)n1)c2-c1cc(CN(C)C)ccc1 Chemical compound Cc([s]c1c2c(NS(c3cc(Cl)ccc3)(=O)=O)cc(C)n1)c2-c1cc(CN(C)C)ccc1 LHTXRSDBPAMQJV-UHFFFAOYSA-N 0.000 description 1
- SFWFUYZHKDMYBQ-UHFFFAOYSA-N Cc1c(-c2n[nH]cc2)[s]c2c1c(NS(c1cc(Cl)ccc1)(=O)=O)cc(C)n2 Chemical compound Cc1c(-c2n[nH]cc2)[s]c2c1c(NS(c1cc(Cl)ccc1)(=O)=O)cc(C)n2 SFWFUYZHKDMYBQ-UHFFFAOYSA-N 0.000 description 1
- HRFVJSUWWDVJGV-UHFFFAOYSA-N Cc1cccc(-c(c(c(N)cc(C)n2)c2[s]2)c2Br)c1 Chemical compound Cc1cccc(-c(c(c(N)cc(C)n2)c2[s]2)c2Br)c1 HRFVJSUWWDVJGV-UHFFFAOYSA-N 0.000 description 1
- BLUQYQOLJSCKJL-UHFFFAOYSA-N Cc1nc([s]c(-c2c[nH]nc2)c2Br)c2c(NS(c2ccccc2)(=O)=O)c1 Chemical compound Cc1nc([s]c(-c2c[nH]nc2)c2Br)c2c(NS(c2ccccc2)(=O)=O)c1 BLUQYQOLJSCKJL-UHFFFAOYSA-N 0.000 description 1
- KDYZYSYNUAMGMY-UHFFFAOYSA-N Cc1nc([s]c(Br)c2-c3cc(Br)ccc3)c2c(NS(c2ccccc2)(=O)=O)c1 Chemical compound Cc1nc([s]c(Br)c2-c3cc(Br)ccc3)c2c(NS(c2ccccc2)(=O)=O)c1 KDYZYSYNUAMGMY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28779809P | 2009-12-18 | 2009-12-18 | |
| US61/287,798 | 2009-12-18 | ||
| PCT/US2010/060696 WO2011075559A1 (en) | 2009-12-18 | 2010-12-16 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013514384A JP2013514384A (ja) | 2013-04-25 |
| JP2013514384A5 JP2013514384A5 (https=) | 2014-01-30 |
| JP5799024B2 true JP5799024B2 (ja) | 2015-10-21 |
Family
ID=44167691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544816A Expired - Fee Related JP5799024B2 (ja) | 2009-12-18 | 2010-12-16 | 新規化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9029545B2 (https=) |
| EP (1) | EP2512242B8 (https=) |
| JP (1) | JP5799024B2 (https=) |
| ES (1) | ES2555393T3 (https=) |
| WO (1) | WO2011075559A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2792068A1 (en) | 2010-04-02 | 2011-10-06 | Senomyx, Inc. | Sweet flavor modifier |
| MX336378B (es) | 2011-08-12 | 2016-01-15 | Senomyx Inc | Modificador del sabor dulce. |
| US9908893B2 (en) | 2013-06-11 | 2018-03-06 | Latvian Institute Of Organic Synthesis | Thieno [2,3-b] pyridines as multidrug resistance modulators |
| JP6466092B2 (ja) * | 2014-07-17 | 2019-02-06 | ナオ・シング株式会社 | 枕による寝姿勢の調整方法および調整枕 |
| CA2963901A1 (en) | 2014-11-07 | 2016-05-12 | Senomyx, Inc. | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
| WO2019023651A2 (en) * | 2017-07-28 | 2019-01-31 | Massachusetts Institute Of Technology | MODULATORS OF THE SMALL MOLECULE ANDROGEN RECEPTOR |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| EP1505068A4 (en) | 2002-04-23 | 2008-03-19 | Shionogi & Co | PYRAZOLO (1,5-a) PYRIMIDINE DERIVATIVE AND INHIBITOR OF NAD (P) H OXIDASE CONTAINING SAID DERIVATIVE |
| EP1598354A1 (en) | 2004-05-18 | 2005-11-23 | Vasopharm Biotech GmbH | Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation |
| AR056200A1 (es) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa |
| JP5219465B2 (ja) * | 2006-11-10 | 2013-06-26 | 大塚製薬株式会社 | 医薬 |
| EP2002835A1 (en) * | 2007-06-04 | 2008-12-17 | GenKyo Tex | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
-
2010
- 2010-12-16 WO PCT/US2010/060696 patent/WO2011075559A1/en not_active Ceased
- 2010-12-16 US US13/516,252 patent/US9029545B2/en not_active Expired - Fee Related
- 2010-12-16 JP JP2012544816A patent/JP5799024B2/ja not_active Expired - Fee Related
- 2010-12-16 EP EP10838240.9A patent/EP2512242B8/en not_active Not-in-force
- 2010-12-16 ES ES10838240.9T patent/ES2555393T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2512242A1 (en) | 2012-10-24 |
| EP2512242B1 (en) | 2015-09-30 |
| EP2512242B8 (en) | 2015-12-09 |
| US20120252805A1 (en) | 2012-10-04 |
| EP2512242A4 (en) | 2013-08-28 |
| WO2011075559A1 (en) | 2011-06-23 |
| ES2555393T3 (es) | 2015-12-30 |
| US9029545B2 (en) | 2015-05-12 |
| JP2013514384A (ja) | 2013-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2878160T3 (es) | Derivados de 5,7-dihidro-pirrolo-piridina para el tratamiento de enfermedades neurológicas y neurodegenerativas | |
| JP6445574B2 (ja) | ブロモドメイン阻害剤 | |
| AU2023207390A1 (en) | Six-membered cyclothiazole compound and use thereof | |
| CA3137025A1 (en) | Bicyclic compounds | |
| BR112021008741A2 (pt) | compostos bicíclicos | |
| JP2020147575A (ja) | 治療用阻害化合物 | |
| CA3013819A1 (en) | Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof | |
| JP5799024B2 (ja) | 新規化合物 | |
| AU2020320001B2 (en) | Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | |
| WO2021226547A2 (en) | Targeted nek7 inhibition for modulation of the nlrp3 inflammasome | |
| JP2014051516A (ja) | タンパク質キナーゼ阻害剤として有用な５−シアノ−４−（ピロロ［２，３ｂ］ピリジン−３−イル）−ピリミジン誘導体 | |
| TW200924778A (en) | Amide compound | |
| KR20150132556A (ko) | 과다증식성 장애의 치료를 위한 3-아세틸아미노-1-(페닐-헤테로아릴-아미노카르보닐 또는 페닐-헤테로아릴-카르보닐아미노)벤젠 유도체 | |
| AU2014234909B2 (en) | Acyclic cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
| JP2021514346A (ja) | 肝再生促進又は肝細胞死の抑制もしくは防止のためのプロテインキナーゼｍｋｋ４阻害剤 | |
| KR20160127138A (ko) | 신규 화합물 | |
| JP2015504086A (ja) | Ｐ２ｘ７受容体アンタゴニストとしての複素環アミド誘導体 | |
| KR20160142402A (ko) | 도파민 d1 리간드로서 헤테로방향족 화합물 및 이의 용도 | |
| JPWO2019189555A1 (ja) | 複素環化合物 | |
| KR20250043398A (ko) | 신규 7-치환 인돌 설폰아미드 유도체 | |
| JP2016124810A (ja) | 新規縮合ピラゾール誘導体およびその医薬用途 | |
| CN117624185A (zh) | Lrrk2抑制剂化合物、药物组合物及其制备方法和应用 | |
| HK40078531B (zh) | 杂芳基化合物 | |
| TW201722962A (zh) | 四氫氧呯並吡啶化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131204 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131204 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20140911 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140911 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141023 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141024 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150126 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150224 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150728 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150824 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5799024 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |